Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects. (February 2022)
- Record Type:
- Journal Article
- Title:
- Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects. (February 2022)
- Main Title:
- Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects
- Authors:
- Rusconi, Stefano
Saladini, Francesco
Bellocchi, Maria Concetta
Galli, Laura
Gagliardini, Roberta
Gazzola, Lidia
Francisci, Daniela
Vichi, Francesca
Focà, Emanuele
Zazzi, Maurizio
Santoro, Maria M.
Gabrieli, Arianna
Castagna, Antonella - Abstract:
- Is Part Of:
- Pharmacological research. Volume 176(2022)
- Journal:
- Pharmacological research
- Issue:
- Volume 176(2022)
- Issue Display:
- Volume 176, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 176
- Issue:
- 2022
- Issue Sort Value:
- 2022-0176-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-02
- Subjects:
- Leronlimab -- Drug resistance -- Genotype -- Phenotype -- Human immunodeficiency virus type 1 -- Maraviroc
Pharmacology -- Periodicals
Pharmacology -- Periodicals
Research -- Periodicals
Médicaments -- Recherche -- Périodiques
Pharmacologie -- Périodiques
615.105 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10436618 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.phrs.2022.106064 ↗
- Languages:
- English
- ISSNs:
- 1043-6618
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6446.550000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20665.xml